04:32 PM EDT, 07/02/2024 (MT Newswires) -- Avid Bioservices ( CDMO ) reported a fiscal Q4 loss late Tuesday of $1.94 per diluted share, wider than a loss of $0.01 a year earlier.

Four analysts polled by Capital IQ expected a loss of $0.04.

Revenue for the quarter ended April 30 was $43.0 million, up from $39.8 million a year earlier.

Analysts polled by Capital IQ expected $42.1 million.

The company said it expects fiscal 2025 revenue between $160 million and $168 million. Analysts polled by Capital IQ expect $164 million.

Shares of the company were up nearly 6% in recent after-hours activity.

Price: 7.10, Change: +0.40, Percent Change: +5.97